What is ABDXF stock price today?

ABDXF (Abingdon Health Plc) stock is trading at $0.07 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ABDXF stock going up or down today?

ABDXF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ABDXF stock now?

The decision to buy ABDXF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ABDXF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ABDXF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ABDXF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ABDXF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ABDXF's P/E ratio?

P/E ratio data for ABDXF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ABDXF's market cap?

ABDXF (Abingdon Health Plc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is ABDXF's price to book ratio?

ABDXF trades at a price-to-book (P/B) ratio of 0.33, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ABDXF pay dividends?

ABDXF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ABDXF's dividend yield?

ABDXF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ABDXF stock a good long-term investment?

ABDXF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ABDXF's revenue growth rate?

ABDXF has shown revenue growth of 0.3% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

ABDXF is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in ABDXF?

Key risks for ABDXF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ABDXF compare to its competitors?

Compare ABDXF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ABDXF's performance and positioning.

What is ABDXF's stock price target for 2026?

Our AI model provides price targets for ABDXF based on fundamental analysis: Bull case $0.09 (+30%), Base case $0.08 (+15%), Bear case $0.06 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ABDXF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ABDXF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ABDXF's next earnings report?

ABDXF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ABDXF - Abingdon Health Plc

NYSE * Healthcare * Diagnostics & Research

$0.07

+$0.00 (+0.00%)

About Abingdon Health Plc

Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

ABDXF Key Statistics

Market Cap

$13.27M

P/B Ratio

0.33

EPS

$-0.05

Revenue Growth

+0.3%

Profit Margin

-0.4%

Employees

113

How ABDXF Compares to Peers

ABDXF ranks 2nd in revenue growth vs peers

ABDXF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ABDXF(This stock)	$13.27M	N/A	0%	-0.4%	-
UNHUnitedhealth Group	$299.85B	17.2	0%	0.0%	vs UNH
JNJJohnson &	$525.73B	21.1	0%	0.3%	vs JNJ
LLYEli Lilly	$933.47B	51.0	1%	0.3%	vs LLY
PFEPfizer Inc	$145.84B	14.9	-0%	0.2%	vs PFE
ABBVAbbvie Inc	$378.84B	161.2	0%	0.0%	vs ABBV

Abingdon Health Plc Company Information

Headquarters: York Biotech Campus, York, United Kingdom, YO41 1LZ, undefined
Website: www.abingdonhealth.com
Sector: Healthcare
Industry: Diagnostics & Research

About Abingdon Health Plc

ABDXF Key Statistics

How ABDXF Compares to Peers

Abingdon Health Plc Company Information

Upcoming Events for ABDXF